4-(4-(3-(2-chlorophenyl)ureido)-1H-pyrazol-1-yl)-N-(oxetan-3-yl)thiophene-2-carboxamide

ID: ALA4753641

PubChem CID: 155803727

Max Phase: Preclinical

Molecular Formula: C18H16ClN5O3S

Molecular Weight: 417.88

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cnn(-c2csc(C(=O)NC3COC3)c2)c1)Nc1ccccc1Cl

Standard InChI:  InChI=1S/C18H16ClN5O3S/c19-14-3-1-2-4-15(14)23-18(26)22-11-6-20-24(7-11)13-5-16(28-10-13)17(25)21-12-8-27-9-12/h1-7,10,12H,8-9H2,(H,21,25)(H2,22,23,26)

Standard InChI Key:  FPVKFPPNOMNINZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   43.9288  -22.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.9277  -23.4904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.6357  -23.8993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.3454  -23.4899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.3425  -22.6672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.6339  -22.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.0537  -23.8974    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   44.6355  -24.7165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.9277  -25.1249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.2201  -24.7162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.9275  -25.9421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.5123  -25.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7667  -24.7950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2198  -25.4022    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.6282  -26.1101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.4275  -25.9402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2945  -26.8575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4951  -27.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4096  -27.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1561  -28.1726    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   41.7029  -27.5653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7018  -28.2485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7017  -29.0657    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.9942  -27.8398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.9943  -27.0226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5711  -26.4464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9934  -25.8684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.4154  -26.4462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  3  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 12  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 17  2  0
 15 17  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4753641

    ---

Associated Targets(Human)

SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK10 Tchem c-Jun N-terminal kinase 3 (3396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK9 Tchem c-Jun N-terminal kinase 2 (4655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mapk10 c-Jun N-terminal kinase 3 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.88Molecular Weight (Monoisotopic): 417.0662AlogP: 3.36#Rotatable Bonds: 5
Polar Surface Area: 97.28Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.54CX Basic pKa: 0.75CX LogP: 2.64CX LogD: 2.64
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -2.28

References

1. Feng Y,Park H,Bauer L,Ryu JC,Yoon SO.  (2021)  Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors.,  12  (1.0): [PMID:33488960] [10.1021/acsmedchemlett.0c00533]
2. Feng Y, Park H, Ryu JC, Yoon SO..  (2021)  N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors.,  12  (10.0): [PMID:34676036] [10.1021/acsmedchemlett.1c00334]

Source